abstract |
The present invention provides substituted pyrazine derivatives of formula (I) are antagonists of CRF 1 receptors, including human CRF 1 receptors. The present invention also provides for treating diseases or conditions such as CNS diseases, particularly anxiety related diseases and mood disorders, where the treatment can be achieved or promoted by antagonizing the CRF receptor. It relates to the use of the compounds of the invention. |